Neurocrine Biosciences Inc
- Stock
- Ticker NBIX
- ISIN US64125C1099
- Nasdaq
Performance, volatility and drawdowns of Neurocrine Biosciences Inc since 11/2016, with distributions reinvested and calculated in US dollars. As of 20 Nov 2026.
Performance
$10,000 grew to $29,587. Global equities (VT): $29,042.
Distributions reinvested, before taxes and brokerage costs. Dashed: Global equities (VT) for comparison.
Declines from the peak
Lowest point −46.4% in 01/2022, measured from the peak in 07/2020. It took 42 months to get back to the old peak.
Financial statements
Amounts in $ millions from filings with the SEC, earnings per share in $; fourth quarter and quarterly cash flow derived from year-to-date figures
| Quarter end | 12/2024 | 03/2025 | 06/2025 | 09/2025 | 12/2025 | 03/2026 | 06/2026 | 09/2026 |
|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||
| Revenue | 628 | 573 | 688 | 795 | 806 | 815 | 959 | 1,123 |
| Gross profit | 618 | 563 | 676 | 781 | 788 | 801 | – | – |
| Operating income | 142 | 24 | 146 | 239 | 211 | 193 | 152 | 331 |
| EBITDA | 148 | 30 | 152 | 246 | 217 | 201 | 160 | 340 |
| Net income | 103 | 7.9 | 108 | 210 | 154 | 198 | 144 | 207 |
| Earnings per share | 1.00 | 0.08 | 1.06 | 2.04 | 1.48 | 1.91 | 1.39 | 1.96 |
| Balance sheet | ||||||||
| Total assets | 3,719 | 3,688 | 3,890 | 4,266 | 4,632 | 4,906 | 5,359 | 5,627 |
| Liabilities | 1,129 | 1,152 | 1,196 | 1,262 | 1,378 | 1,499 | 1,666 | 1,749 |
| Equity | 2,590 | 2,536 | 2,694 | 3,004 | 3,253 | 3,407 | 3,694 | 3,879 |
| Cash | 233 | 194 | 264 | 340 | 713 | 267 | 332 | 642 |
| Cash flow | ||||||||
| Operating cash flow | 243 | 65 | 102 | 228 | 388 | 146 | 136 | 395 |
| Capital expenditure | -7.3 | -11 | -13 | -13 | 2.4 | -9.1 | -7.8 | -12 |
| Free cash flow | 235 | 54 | 90 | 214 | 391 | 137 | 129 | 384 |
Value it:DCF calculatorMultiples calculator
Annual returns
Best year 2017 at +100.5%, weakest 2021 at −11.1%. 6 of 9 full years were positive. * partial year.
Quarterly reports
Filing date with the SEC and earnings per share of the quarter
| Day | Earnings per share |
|---|---|
| 2 Nov 2026 | $1.96 |
| 31 Jul 2026 | $1.39 |
| 5 May 2026 | $1.91 |
| 11 Feb 2026 | $1.48 |
| 28 Oct 2025 | $2.04 |
| 30 Jul 2025 | $1.06 |
| 5 May 2025 | $0.08 |
| 10 Feb 2025 | $1.00 |
| 30 Oct 2024 | $1.24 |
| 1 Aug 2024 | $0.63 |
| 1 May 2024 | $0.42 |
| 9 Feb 2024 | $1.46 |
Key metrics
Metrics of 15 Nov 2026; P/E, P/B, P/S, market cap and dividend yield at the last close.
Valuation
- Market cap
- €14bn
- Market cap in trading currency
- $15.2bn
- Enterprise value
- $14.5bn
- P/E
- 22.3
- P/S
- 4.12
- P/B
- 3.93
- EV/Sales
- 3.92
- EV/EBITDA
- 15.8
- Earnings yield
- 4.5%
- FCF yield
- 6.8%
Results (last four quarters)
- Revenue
- $3.70bn
- Gross profit
- –
- EBITDA
- $918m
- Net income
- $703m
- Earnings per share
- $6.74
- Revenue per share
- $36.57
- Revenue growth
- +41.2%
- Earnings growth
- −1.4%
Profitability
- Gross margin
- –
- Operating margin
- 24.0%
- Net margin
- 19.0%
- Return on equity
- 20.4%
- Return on assets
- 12.5%
Balance sheet and cash flow
- Cash
- $738m
- Cash per share
- $7.29
- Financial debt
- –
- Debt/equity %
- –
- Current ratio
- 2.04
- Book value per share
- $38.32
- Operating cash flow
- $1.07bn
- Free cash flow
- $1.04bn
Dividend
- Dividend yield
- 0.00%
- Dividend (12 months)
- $0.00
- Yield (12 months)
- 0.00%
- Payout ratio
- 0%
- Ex-dividend date
- –
Shares and trading
- Shares outstanding
- 101m
- Volume
- 1.53m
- Avg. volume 3 months
- 1.31m
- Relative volume
- 1.2
Price and technicals
- Price
- $150.57
- 1 day
- −3.8%
- 52-week high
- $185.50
- 52-week low
- $123.10
- Distance to 52-week high
- −18.8%
- Distance to 52-week low
- +22.3%
- Distance to 50-day line
- +1.0%
- Distance to 200-day line
- +0.8%
- RSI (14)
- 43
- Volatility 1M
- 56.0%
Performance
- 1 week
- −10.1%
- 1 month
- +5.1%
- 3 months
- −1.6%
- 6 months
- −3.9%
- YTD
- +6.2%
- 1 year
- +9.1%
Dates
- Fiscal year end
- 31 Dec 2025
- Most recent quarter
- 30 Sep 2026
Frequently asked questions
How has NBIX performed since 11/2016?
$10,000 grew to $29,587 by 20 Nov 2026, which is +11.5% per year. Distributions are reinvested; taxes and brokerage costs are not deducted.
How volatile is NBIX?
Volatility was 34.1% per year, measured on monthly returns. The largest decline from a peak was −46.4%, with the low in 01/2022.
How does NBIX compare with a broad equity ETF?
Over the same period Global equities (VT) returned +11.3% per year at 15.1% volatility, NBIX returned +11.5% at 34.1%. The correlation of monthly returns was 0.22; 1 would mean they moved in lockstep.
Which currency are the figures in?
In US dollars, the currency of the US listing.